# Carter BloodCare Paris – FDA Inspection, Aug 13, 2009

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-paris/c50eb9c1-8c1a-49b3-a6cb-552439eaad91
Source feed: FDA_Inspections

> FDA inspection 604692 of Carter BloodCare Paris, August 13, 2009. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 604692
- Company Name: Carter BloodCare Paris
- Inspection Date: 2009-08-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1119839 - 2020-02-25
- FDA Inspection 1041613 - 2018-02-09
- FDA Inspection 810140 - 2012-12-11
- FDA Inspection 729702 - 2011-06-14

Company: https://www.keypedia.com/companies/carter-bloodcare-paris/c0bcd295-31c2-48e3-a847-451d545524d7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d